GFAP and Alexander disease: This report shows that upregulation of Csf1 is a consistent feature of AxD models and that administration of the CSF1R inhibitor PEX to AxD model mice results in CNS macrophage depletion and elevated GFAP protein levels but did not lead to significant changes in many other disease phenotypes.